Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

50543

registered interest
date	12/05/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much was spent on operating breast network site specific groups in (a) 2010-11, (b) 2011-12 and (c) 2012-13.
tabling member constituency	Basildon and Billericay
tabling member printed	Mr John Baron
uin	198405
answer	answer is ministerial correction date of answer 14/05/2014 answer text <p>Strategic Clinical Networks (SCNs) are funded by NHS England and managed through Area Teams. Their role is to support clinical commissioning groups, Health and Wellbeing Boards and NHS England to make the best decisions about healthcare for the populations they serve by providing advice and leadership at a strategic level. NHS England advises that it does not routinely hold detail on SCN funding in the format requested.</p><p> </p><p>The Department does not hold information centrally on how much was spent on operating breast network site specific groups prior to the establishment of SCNs on 1 April 2013.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 198401 198402 198403 question first answered 14/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
tabling member	1390 label Biography information for Mr John Baron

50544

registered interest
date	12/05/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much funding was allocated by each of the 12 strategic clinical networks for a breast network site specific group in 2013-14.
tabling member constituency	Basildon and Billericay
tabling member printed	Mr John Baron
uin	198403
answer	answer is ministerial correction date of answer 14/05/2014 answer text <p>Strategic Clinical Networks (SCNs) are funded by NHS England and managed through Area Teams. Their role is to support clinical commissioning groups, Health and Wellbeing Boards and NHS England to make the best decisions about healthcare for the populations they serve by providing advice and leadership at a strategic level. NHS England advises that it does not routinely hold detail on SCN funding in the format requested.</p><p> </p><p>The Department does not hold information centrally on how much was spent on operating breast network site specific groups prior to the establishment of SCNs on 1 April 2013.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 198401 198402 198405 question first answered 14/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
tabling member	1390 label Biography information for Mr John Baron

50545

registered interest
date	12/05/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much funding is planned to be provided to cancer strategic clinical networks in 2014-15.
tabling member constituency	Basildon and Billericay
tabling member printed	Mr John Baron
uin	198402
answer	answer is ministerial correction date of answer 14/05/2014 answer text <p>Strategic Clinical Networks (SCNs) are funded by NHS England and managed through Area Teams. Their role is to support clinical commissioning groups, Health and Wellbeing Boards and NHS England to make the best decisions about healthcare for the populations they serve by providing advice and leadership at a strategic level. NHS England advises that it does not routinely hold detail on SCN funding in the format requested.</p><p> </p><p>The Department does not hold information centrally on how much was spent on operating breast network site specific groups prior to the establishment of SCNs on 1 April 2013.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 198401 198403 198405 question first answered 14/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
tabling member	1390 label Biography information for Mr John Baron

50546

registered interest
date	12/05/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much funding has been allocated by each of the 12 strategic clinical networks for the running of a breast network site specific group in 2014-15.
tabling member constituency	Basildon and Billericay
tabling member printed	Mr John Baron
uin	198401
answer	answer is ministerial correction date of answer 14/05/2014 answer text <p>Strategic Clinical Networks (SCNs) are funded by NHS England and managed through Area Teams. Their role is to support clinical commissioning groups, Health and Wellbeing Boards and NHS England to make the best decisions about healthcare for the populations they serve by providing advice and leadership at a strategic level. NHS England advises that it does not routinely hold detail on SCN funding in the format requested.</p><p> </p><p>The Department does not hold information centrally on how much was spent on operating breast network site specific groups prior to the establishment of SCNs on 1 April 2013.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 198402 198403 198405 question first answered 14/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
tabling member	1390 label Biography information for Mr John Baron

50560

registered interest
date	12/05/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many publicly accessible defibrillators there are in (a) Hampshire and (b) Southampton; and whether there is a register or map showing where such defibrillators are located.
tabling member constituency	Romsey and Southampton North
tabling member printed	Caroline Nokes
uin	198420
answer	answer is ministerial correction date of answer 14/05/2014 answer text <p>The South Central Ambulance NHS Foundation Trust is responsible for the deployment and use of public access defibrillators in Hampshire and Southampton.</p><p> </p><p>According to the information collected bythe trust, there are at least 263 public access defibrillators across Hampshire, and nine in Southampton.</p><p> </p><p>A map of the locations of the defibrillators is available on the trust's website at:</p><p> </p><p>www.scas.nhs.uk/campaigns/startaheart.ashx</p><p> </p><p>The trust has also developed a mobile phone application which displays the location of available units to users, which is also available through its website.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 14/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
tabling member	4048 label Biography information for Caroline Nokes

50606

registered interest
date	12/05/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what response his Department plans to make to the findings and recommendations of the All-Party Parliamentary Hepatology Group's recent report into liver disease, Today's Complacency, Tomorrow's Catastrophe, published on 25 March 2014; and if he will make a statement.
tabling member constituency	Batley and Spen
tabling member printed	Mike Wood
uin	198359
answer	answer is ministerial correction date of answer 14/05/2014 answer text <p>Improving outcomes for people with liver disease is a priority and tackling it is reflected in the NHS Outcomes Framework, the Public Health Outcomes Framework and in the Government's mandate to the National Health Service.</p><p> </p><p>Building on last year's ‘Call to Action', <em>Living Well for Longer: National Support for Local Action to Reduce Premature Avoidable Mortality</em> brings together the national actions which will be taken by the Department and wider Government, NHS England and Public Health England (PHE), to reduce premature mortality in England. It focuses on the five big killers including liver disease and includes a system wide delivery plan for 2014-15. This plan reflects the key actions which will be taken to reduce premature mortality taking into account the commitments that each of these organisations have made in their 2014-15 business plan. Progress against these commitments will be tracked and reported on next year.</p><p> </p><p>In addition, PHE is meeting with the All-Party Parliamentary Hepatology Group, and other stakeholders, in July to discuss the recommendations of its recent report into liver disease.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 198362 question first answered 14/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
tabling member	401 label Biography information for Mike Wood

50607

registered interest
date	12/05/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to ensure that his Department, NHS England, Public Health England, clinical commissioning groups and local authorities co-ordinate a national approach to improving the prevention, testing, diagnosis and treatment of Hepatitis C.
tabling member constituency	Batley and Spen
tabling member printed	Mike Wood
uin	198360
answer	answer is ministerial correction date of answer 14/05/2014 answer text <p>Public Health England is currently working with NHS England and other partners to reduce the burden of disease from hepatitis C through a suite of activities to improve awareness, prevention, testing and diagnosis, referral into care, and treatment outcomes. The Department is supportive of this work, and is helping to facilitate it.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 14/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
tabling member	401 label Biography information for Mike Wood

50608

registered interest
date	12/05/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the feasibility of effectively eliminating Hepatitis C in the UK in the next 15 to 20 years.
tabling member constituency	Batley and Spen
tabling member printed	Mike Wood
uin	198361
answer	answer is ministerial correction date of answer 14/05/2014 answer text <p>Public Health England (PHE) is committed to working with NHS England and other partners to reduce the burden of disease from hepatitis C through a suite of activities to improve awareness, prevention, testing and diagnosis, referral into care, and treatment outcomes</p><p> </p><p> </p><p>The feasibility of elimination – that is the reduction to zero of the incidence of disease or infection in England - has not been formally assessed and it is likely to be difficult in the absence of an effective vaccine. However, PHE has recently completed modelling work to assess the potential impact of increased uptake and new therapies on reducing the future burden of hepatitis C-related end stage liver disease in England. This work is being finalised and will be published shortly.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 14/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
tabling member	401 label Biography information for Mike Wood

50609

registered interest
date	12/05/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of progress in reducing avoidable deaths from liver disease as set out in his call to action to reduce avoidable premature mortality; and what further steps his Department will be taking.
tabling member constituency	Batley and Spen
tabling member printed	Mike Wood
uin	198362
answer	answer is ministerial correction date of answer 14/05/2014 answer text <p>Improving outcomes for people with liver disease is a priority and tackling it is reflected in the NHS Outcomes Framework, the Public Health Outcomes Framework and in the Government's mandate to the National Health Service.</p><p> </p><p>Building on last year's ‘Call to Action', <em>Living Well for Longer: National Support for Local Action to Reduce Premature Avoidable Mortality</em> brings together the national actions which will be taken by the Department and wider Government, NHS England and Public Health England (PHE), to reduce premature mortality in England. It focuses on the five big killers including liver disease and includes a system wide delivery plan for 2014-15. This plan reflects the key actions which will be taken to reduce premature mortality taking into account the commitments that each of these organisations have made in their 2014-15 business plan. Progress against these commitments will be tracked and reported on next year.</p><p> </p><p>In addition, PHE is meeting with the All-Party Parliamentary Hepatology Group, and other stakeholders, in July to discuss the recommendations of its recent report into liver disease.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 198359 question first answered 14/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
tabling member	401 label Biography information for Mike Wood

50621

registered interest
date	12/05/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what funding his Department has made available in Lancashire to improve the early diagnosis of breast cancer.
tabling member constituency	Fylde
tabling member printed	Mark Menzies
uin	198388
answer	answer is ministerial correction date of answer 14/05/2014 answer text <p><em>Improving Outcomes: A Strategy for Cancer</em>, published in January 2011, committed over £450 million over the four years up to 2014/15 to achieve earlier diagnosis of cancer. The earlier diagnosis money also included central funding for Be Clear on Cancer campaigns.</p><p> </p><p>The Department provided £2.5 million in 2010/11 to support 18 local awareness campaigns, including seven intended to raise awareness of breast cancer in women over 70. Lancashire and South Cumbria Cancer Network area was one of the pilot areas. In 2014, we funded a national campaign on breast cancer in women over 70 at a cost of around £2.2 million.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 14/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
tabling member	3998 label Biography information for Mark Menzies